Polyzos N P, Popovic-Todorovic B
Department of Reproductive Medicine, Dexeus University Hospital, Barcelona, Spain.
Centre for Reproductive Medicine, UZ Brussel, 1090 Jette, Belgium.
Hum Reprod. 2020 Sep 1;35(9):1964-1971. doi: 10.1093/humrep/deaa183.
Over the last 25 years, a vast body of literature has been published evaluating different treatment modalities for the management of poor ovarian responders. Despite the evidence that maximizing ovarian response can improve the chances of live born babies in poor responders, there are still voices suggesting that all poor responders are the same, irrespective of their age and their actual ovarian reserve. This has resulted in the suggestion of adopting a mild ovarian stimulation approach for all poor responders, based on the results of several trials which failed to identity differences when comparing mild and more intense stimulation in predicted poor responders. The current article analyzes in detail these studies and discusses the shortcomings in terms of type of population included, outcomes and settings performed, which may actually be responsible for the belief that only mild stimulation should be used. In the era of individualization in medicine, it must be realized that there are subgroups of predicted poor responders who will benefit from an individual rather than 'one fits all' mild stimulation approach and thus we should provide the same standard of treatment for all our poor responder patients.
在过去25年里,已经发表了大量文献,评估针对卵巢反应不良者的不同治疗方式。尽管有证据表明,使卵巢反应最大化可以提高卵巢反应不良者活产婴儿的几率,但仍有观点认为,所有卵巢反应不良者都是一样的,无论其年龄和实际卵巢储备如何。基于几项试验的结果,有人建议对所有卵巢反应不良者采用温和的卵巢刺激方法,这些试验在比较预测的卵巢反应不良者的温和刺激和更强烈刺激时未能发现差异。本文详细分析了这些研究,并讨论了所纳入人群类型、所进行的结果和环境方面的缺点,这些缺点可能实际上导致了认为只应使用温和刺激的观点。在医学个体化的时代,必须认识到,有一部分预测的卵巢反应不良者亚组将从个体化而非“一刀切”的温和刺激方法中受益,因此我们应该为所有卵巢反应不良患者提供相同的治疗标准。